NGVT
$67.86
Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments:...
Recent News
Ingevity Corp (NGVT) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Innovations ...
Ingevity Corp (NGVT) reports strong revenue growth and market expansion, while navigating supply chain disruptions and rising costs.
How Asset Impairment, Divestitures, and Buybacks Will Impact Ingevity (NGVT) Investors
Ingevity Corporation reported past fourth-quarter 2025 sales of US$255.1 million, a net loss of US$84.6 million driven by a US$109.3 million long‑lived asset impairment, and full‑year 2025 sales of US$1.17 billion with a reduced annual net loss of US$167.1 million. Alongside these results, Ingevity outlined 2026 sales guidance of US$1.1 billion to US$1.2 billion, continued portfolio reshaping through asset sales, and a sizeable share repurchase plan through 2027 that collectively point to a...
Ingevity Q4 Earnings Call Highlights
Ingevity (NYSE:NGVT) executives told investors the company delivered higher profitability and cash flow in 2025 despite lower sales, while continuing to reshape its portfolio through divestitures and planned asset sale processes. Management also outlined 2026 guidance that excludes the recently dive
NGVT Reports Losses in Q4, Missing Estimates, Revenues Dip Y/Y
Ingevity swings to a loss in Q4, missing EPS estimates as revenues fall 3% on weak auto demand and polymer sales.
Ingevity (NGVT) Q4 2025 Earnings Call Transcript
David H. Li: Thank you, Savi, and good morning, everyone. During this presentation, we laid out our plans for growing adjusted earnings per share by 10% and free cash flow per share by 5% through 2027.